NCT05495581View on ClinicalTrials.gov

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 25, 2022

Primary Completion Date

April 27, 2023

Study Completion Date

May 8, 2023

Conditions
Healthy VolunteersRenal Impairment
Interventions
DRUG

pudexacianinium chloride

Intravenous

Trial Locations (4)

33147

Advanced Pharma CR, LLC, Miami

36207

Pinnacle Research Group, Anniston

92780

Orange County Research Center, Tustin

Unknown

Sekino Clinical Pharmacology Clinic, Toshima-ku

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY